Related Experiment Video
Updated: May 28, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Prostaglandin catabolic enzymes as tumor suppressors
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA. htai1@uky.edu
Abstract:
15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is a key prostaglandin catabolic enzyme catalyzing the oxidation and inactivation of prostaglandin E(2) (PGE(2)) synthesized from the cyclooxygenase (COX) pathway. Accumulating evidence indicates that 15-PGDH may function as a tumor suppressor antagonizing the action of COX-2 oncogene. 15-PGDH has been found to be down-regulated contributing to elevated levels of PGE(2) in most tumors. The expression of 15-PGDH and COX-2 appears to be regulated reciprocally in cancer cells. Down-regulation of 15-PGDH in tumors is due, in part, to transcriptional repression and epigenetic silencing. Numerous agents have been found to up-regulate 15-PGDH by down-regulation of transcriptional repressors and by attenuation of the turnover of the enzyme. Up-regulation of 15-PGDH may provide a viable approach to cancer chemoprevention. Further catabolism of 15-keto-prostaglandin E(2) is catalyzed by 15-keto-prostaglandin-∆(13)-reductase (13-PGR), which also exhibits LTB(4)-12-hydroxydehydrogenase (LTB(4)-12-DH) activity. 13-PGR/LTB(4)-12-DH behaves as a tumor suppressor as well. This review summarizes current knowledge of the expression and function of 15-PGDH and 13-PGR/LTB(4)-12-DH in lung and other tissues during tumor progression. Future directions of research on these prostaglandin catabolic enzymes as tumor suppressors are also discussed.
Insights
15-Hydroxyprostaglandin dehydrogenase (15-PGDH) and 13-keto-prostaglandin-∆(13)-reductase (13-PGR) are key tumor suppressor enzymes. Their down-regulation in cancer elevates prostaglandin E2 (PGE2) levels, promoting tumor growth.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) catabolizes prostaglandin E2 (PGE2), a pro-tumorigenic mediator.
- 15-PGDH acts as a tumor suppressor by antagonizing the oncogenic COX-2 pathway.
- Reduced 15-PGDH expression is observed in many tumors, leading to increased PGE2 levels.
Purpose of the Study:
- To review the expression and function of 15-PGDH and 13-keto-prostaglandin-∆(13)-reductase (13-PGR) in tumor progression.
- To discuss the role of these enzymes as tumor suppressors.
- To highlight potential therapeutic strategies involving these enzymes for cancer chemoprevention.
Main Methods:
- Literature review of studies on 15-PGDH and 13-PGR in cancer.
- Analysis of molecular mechanisms regulating 15-PGDH expression, including transcriptional repression and epigenetic silencing.
- Examination of the reciprocal regulation between 15-PGDH and COX-2 in cancer cells.
Main Results:
- 15-PGDH and 13-PGR function as tumor suppressors by reducing pro-tumorigenic prostaglandins.
- Tumorigenesis is associated with down-regulation of 15-PGDH and 13-PGR.
- Agents that up-regulate 15-PGDH show promise for cancer chemoprevention.
Conclusions:
- 15-PGDH and 13-PGR are critical regulators of prostaglandin metabolism with significant tumor-suppressive roles.
- Targeting these enzymes offers a potential avenue for cancer prevention and therapy.
- Further research into the regulation and therapeutic application of these enzymes is warranted.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity
Abnormal Proliferation
